Page 202 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

CHAPTER 11 Interventional Oncology 181

24. Mendenhall WM, Riggs CE, Vaysberg M, et al.: Altered fraction- 45. Culp WTN, Johnson EG, Palm CA, et al.: Prostatic artery embo-
ation and adjuvant chemotherapy for head and neck squamous cell lization: early results of a novel treatment for prostatic neoplasia
carcinoma, Head Neck 32:939–945, 2010. in canine patients. In: Proceedings, Veterinary Society of Surgical
VetBooks.ir 25. Myint WK, Ng C, Raaphorst GP: Examining the non-homologous 46. Marioni-Henry K, Schwarz T, Weisse C, et al.: Cystic nasal adeno-
Oncology Meeting. Napa, CA, 2016.
repair process following cisplatin and radiation treatments, Int J
Radiat Biol 78:417–424, 2002.
26. McCaw DL: Radiation and cisplatin for treatment of canine urinary carcinoma in a cat treated with piroxicam and chemoembolization,
J Am Anim Hosp Assoc 43:347–351, 2007.
bladder carcinoma, Veterinary Radiology 29:264–268, 1988. 47. Gillams AR: Image guided tumour ablation, Cancer Imaging 5:103–
27. Powers BE, Withrow SJ, Thrall DE, et al.: Percent tumor necrosis 109, 2005.
as a predictor of treatment response in canine osteosarcoma, Cancer 48. Facciorusso A, Serviddio G, Muscatiello N: Local ablative treatments
67:126–134, 1991. for hepatocellular carcinoma: an updated review, World J Gastrointest
28. Withrow SJ, Thrall DE, Straw RC, et al.: Intra-arterial cisplatin with Pharmacol Ther 7:477–489, 2016.
or without radiation in limb-sparing for canine osteosarcoma, Can- 49. Rombouts SJ, Vogel JA, van Santvoort HC, et al.: Systematic review
cer 71:2484–2490, 1993. of innovative ablative therapies for the treatment of locally advanced
29. Heidner GL, Page RL, McEntee MC, et al.: Treatment of canine pancreatic cancer, Br J Surg 102:182–193, 2015.
appendicular osteosarcoma using cobalt 60 radiation and intraarte- 50. Rasor L, Pollard R, Feldman EC: Retrospective evaluation of three
rial cisplatin, J Vet Intern Med 5:313–316, 1991. treatment methods for primary hyperparathyroidism in dogs, J Am
30. Culp WT, Weisse C, Berent AC, et al.: Early tumor response to Anim Hosp Assoc 43:70–77, 2007.
intraarterial or intravenous administration of carboplatin to treat 51. Pollard RE, Long CD, Nelson RW, et al.: Percutaneous ultra-
naturally occurring lower urinary tract carcinoma in dogs, J Vet sonographically guided radiofrequency heat ablation for treat-
Intern Med 29:900–907, 2015. ment of primary hyperparathyroidism in dogs, J Am Vet Med Assoc
31. Lubarsky M, Ray CE, Funaki B: Embolization agents-which one 218:1106–1110, 2001.
should be used when? Part 1: large-vessel embolization, Semin Inter- 52. Bucy D, Pollard R, Nelson R: Analysis of factors affecting outcome of
vent Radiol 26:352–357, 2009. ultrasound-guided radiofrequency heat ablation for treatment of primary
32. Breedis C, Young G: The blood supply of neoplasms in the liver, Am hyperparathyroidism in dogs, Vet Radiol Ultrasound 58:83–89, 2017.
J Pathol 30:969–977, 1954. 53. Culp WTN, Johnson EG, Palm CA, et al.: Use of thermal abla-
33. Molvar C, Lewandowski RJ: Intra-arterial therapies for liver masses: tion techniques in the treatment of canine urogenital neoplasia. In
data distilled, Radiol Clin North Am 53:973–984, 2015. Proceedings. Veterinary Interventional Radiology and Interven-
34. Gbolahan OB, Schacht MA, Beckley EW, et al.: Locoregional and tional Endoscopy Society Meeting, Cabo San Lucas, Mexico, 2017.
systemic therapy for hepatocellular carcinoma, J Gastrointest Oncol 54. Simon CJ, Dupuy DE: Image-guided ablative techniques in pelvic
8:215–228, 2017. malignancies: radiofrequency ablation, cryoablation, microwave
35. Pesapane F, Nezami N, Patella F, et al.: New concepts in embolo- ablation, Surg Oncol Clin N Am 14:419–431, 2005.
therapy of HCC, Med Oncol 34:58, 2017. 55. Vogl TJ, Naguib NN, Lehnert T, et al.: Radiofrequency, microwave
36. De Maio E, Fiore F, Daniele B, et al.: Transcatheter arterial proce- and laser ablation of pulmonary neoplasms: clinical studies and
dures in the treatment of patients with hepatocellular carcinoma: a technical considerations—review article, Eur J Radiol 77:346–357,
review of literature, Crit Rev Oncol Hematol 46:285–295, 2003. 2011.
37. Carter S, Martin Ii RC: Drug-eluting bead therapy in primary and 56. Mazzaccari K, Boston SE, Toskich BB, et al.: Video-assisted micro-
metastatic disease of the liver, HPB (Oxford) 11:541–550, 2009. wave ablation for the treatment of a metastatic lung lesion in a dog
38. Nakakuma K, Tashiro S, Hiraoka T, et al.: Studies on anticancer with appendicular osteosarcoma and hypertrophic osteopathy, Vet
treatment with an oily anticancer drug injected into the ligated feed- Surg 46:1161–1165, 2017.
ing hepatic artery for liver cancer, Cancer 52:2193–2200, 1983. 57. Yang T, Case JB, Boston S, et al.: Microwave ablation for treatment
39. Cave TA, Johnson V, Beths T, et al.: Treatment of unresectable of hepatic neoplasia in five dogs, J Am Vet Med Assoc 250:79–85,
hepatocellular adenoma in dogs with transarterial iodized oil and 2017.
chemotherapy with and without an embolic agent: a report of two 58. Murphy SM, Lawrence JA, Schmiedt CW, et al.: Image-guided
cases, Vet Comp Oncol 1:191–199, 2003. transnasal cryoablation of a recurrent nasal adenocarcinoma in a
40. Weisse C, Clifford CA, Holt D, et al.: Percutaneous arterial embo- dog, J Small Anim Pract 52:329–333, 2011.
lization and chemoembolization for treatment of benign and 59. Weisse C, Berent A, Solomon S: Combined transarterial emboliza-
malignant tumors in three dogs and a goat, J Am Vet Med Assoc tion, systemic cyclophosphamide, and cryotherapy ablation for “Hi-
221:1430–1436, 2002. Lo” maxillary fibrosarcoma in a dog, In: Proceedings. 8th Annual
41. Oishi Y, Tani K, Ozono K, et al.: Transcatheter arterial embolization Meeting, Veterinary Endoscopy Society, 22.
in normal canine liver, Vet Surg 46:797–802, 2017. 60. Brace C: Thermal tumor ablation in clinical use, IEEE Pulse 2:28–
42. Iwai S, Okano S, Chikazawa S, et al.: Transcatheter arterial emboli- 38, 2011.
zation for treatment of hepatocellular carcinoma in a cat, J Am Vet 61. Kopelman D, Inbar Y, Hanannel A, et al.: Magnetic resonance-
Med Assoc 247:1299–1302, 2015. guided focused ultrasound surgery (MRgFUS). Four ablation treat-
43. Golzarian J, Antunes AA, Bilhim T, et al.: Prostatic artery emboliza- ments of a single canine hepatocellular adenoma, HPB (Oxford)
tion to treat lower urinary tract symptoms related to benign prostatic 8:292–298, 2006.
hyperplasia and bleeding in patients with prostate cancer: proceed- 62. Cerf DJ, Lindquist EC: Palliative ultrasound-guided endoscopic
ings from a multidisciplinary research consensus panel, J Vasc Interv diode laser ablation of transitional cell carcinomas of the lower uri-
Radiol 25:665–674, 2014. nary tract in dogs, J Am Vet Med Assoc 240:51–60, 2012.
44. Sun F, Sanchez FM, Crisostomo V, et al.: Transarterial prostatic 63. Lyu T, Wang X, Su Z, et al.: Irreversible electroporation in primary
embolization: initial experience in a canine model, AJR Am J Roent- and metastatic hepatic malignancies: a review, Medicine (Baltimore)
genol 197:495–501, 2011. 96:e6386, 2017.